CompletedPhase 4NCT00634569
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects
Studying OBSOLETE: Other complex syndrome of primary immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Grifols, S.A.
- Principal Investigator
- Mark Ballow, MDChildren's Hospital of Buffalo
- Intervention
- Flebogamma 5% DIF(biological)
- Enrollment
- 24 enrolled
- Eligibility
- 2-16 years · All sexes
- Timeline
- 2008 – 2011
Study locations (7)
- University of South Florida, St. Petersburg, Florida, United States
- Family Allergy & Asthma Center, PC, Atlanta, Georgia, United States
- Rush University Medical Center, Chicago, Illinois, United States
- The Allergy and Asthma Center, Fort Wayne, Indiana, United States
- The Children's Hospital of Buffalo, Buffalo, New York, United States
- Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
- Children's Hospital and Regional Medial Center, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00634569 on ClinicalTrials.govOther trials for OBSOLETE: Other complex syndrome of primary immunodeficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06332196Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric LymphomasMeyer Children's Hospital IRCCS
- RECRUITINGNCT04990908Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care UnitUniversity Hospital, Montpellier
- RECRUITINGPHASE2NCT05421325Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older AdultsQu Biologics Inc.
- RECRUITINGNCT04784364Biologics And Clinical Immunology Cohort at SinaiIcahn School of Medicine at Mount Sinai
- ACTIVE NOT RECRUITINGPHASE3NCT04565015Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral ImmunodeficiencyGC Biopharma Corp
- RECRUITINGNCT04459689COVID-19 in PID SurveyImagine Institute
- RECRUITINGPHASE2NCT04232085Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow FailuresSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- ACTIVE NOT RECRUITINGPHASE2NCT01821781Immune Disorder HSCT ProtocolWashington University School of Medicine
See all trials for OBSOLETE: Other complex syndrome of primary immunodeficiency →